Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis

Acta Haematol. 2012;128(1):20-2. doi: 10.1159/000337341. Epub 2012 May 8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Bone Marrow / pathology
  • HIV / genetics
  • HIV / immunology
  • HIV Infections / diagnosis
  • Humans
  • Immunophenotyping
  • Kidney / parasitology
  • Kidney / pathology
  • Leishmania infantum / isolation & purification
  • Leishmaniasis, Visceral / complications
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy
  • Liver / parasitology
  • Liver / pathology
  • Lymphoma, B-Cell, Marginal Zone / complications
  • Lymphoma, B-Cell, Marginal Zone / diagnosis*
  • Lymphoma, B-Cell, Marginal Zone / pathology
  • Macrophages / parasitology
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Phosphorylcholine / analogs & derivatives
  • Phosphorylcholine / therapeutic use
  • Positron-Emission Tomography
  • Splenic Neoplasms / complications
  • Splenic Neoplasms / diagnosis*
  • Splenic Neoplasms / pathology
  • Tomography, X-Ray Computed

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine
  • Amphotericin B